Californians waiting for a coronavirus vaccine will have to wait even longer.Gov. Gavin Newsom said he wants the state’s top health care professionals to approve any vaccine before making it available statewide.“Of course, we don’t take anyone’s word for it,” Newsom said Monday during a news conference. “We will do our own independently reviewed process with our world-class experts that just happen to live here in the state of California.”KCRA 3's Emily Maher talked to UC Davis Health CEO Dr. David Lubarsky and Dr. Mark Walberg with GlaxoSmithKline about the decision.Lubarsky said he supports Newsom's decision and Walberg said he disagrees with the plan. Dr. David Lubarsky, UC Davis Health CEOQ: What is your reaction to the governor’s decision?Lubarsky: I think that’s an incredibly appropriate and reasonable idea. As part of the University of California, we had decided, prior to recommending the vaccine to our own patients, we were going to have our own expert evaluate it, just given all the political pressure and concerns that have been expressed. While we have the greatest faith in the FDA, it would make our patients feel more assured that it was indeed safe. I think it’s a wise move.Q: What do you know about the panel appointed to approve a COVID-19 vaccine?Lubarsky: Knowing that some of my colleagues are on the panel, I can assure you that they have been reviewing every single paper and every single detail available in the public sphere since this all began. UC Davis Health is heavily involved in the recruitment of patients for the Pfizer vaccine, so we’re very familiar with that ourselves, and we are confident that work is being done well by Pfizer.Q: Do you think other states will follow California’s lead?Lubarsky: I think, sadly, that we will see a red-state, blue-state distribution of concern. The public’s health is not a political issue. I wish that 100% of Americans had the same faith in the FDA that we had years ago. That has been tempered recently. We just have to accept that and adjust to it.Dr. Mark Walberg, GlaxoSmithKline and associate clinical professor at University of the PacificQ: What is your reaction to the governor’s decision?Walberg: We have the (CDC) Advisory Committee on Immunizations that oversees all of this. I don’t really understand how we’re doing something like that for vaccines when it’s not in place for so many other medications. I really don’t see how this is benefitting or adding an extra layer of protection for California residents.Q: Do you think other states will follow California’s lead?Walberg: I think we need to not politicize science. I think we need to not politicize a public health response like this because what we’ve turned it into on the flip side is, we’ve turned it into social media distorting things, amplifying people’s fears, amplifying people’s partisanship in this. This shouldn’t be a red-state, blue-state thing. This should be about red, white and blue and supporting everyone with the resources we have in this country.Q: Do you think the governor’s decision will benefit Californians?Walberg: I don’t see how this is going to make things safe. The data is the data, when it finally comes out. People have asked, "What do you think of the vaccine?" And I just said, "We don’t have the data yet to really rule on it." Let the FDA, let the CDC do what they were built to do and what their track record has proven they can do, and let’s get this vaccine to the people that need it.